Longxuetongluo capsule inhibits atherosclerosis progression in high-fat diet-induced ApoEâ/â mice by improving endothelial dysfunction

Article ID	Journal	Published Year	Pages	File Type
5599728	Atherosclerosis	2016	33 Pages	PDF

Abstract

These findings suggest the potential of LTC for use as an effective agent against atherosclerosis.

Keywords

eNOS inhibitor of kappa B kinase Ox-LDL ORO VCAM-1 HDLC IKK IκB NF-κB MCP-1 HFD HUVECS COX-2 PBS DMEM FBS LTC MAPK Endothelial dysfunction Oct Triglycerides standard error of the mean optimum cutting temperature Oil red O high-fat diet fetal bovine serum Human umbilical vein endothelial cells endothelial nitric oxide synthase Cyclooxygenase-2 Anti-atherosclerosis nuclear factor kappa B Phosphate buffered saline Oxidized low-density lipoprotein Dulbecco’s modified eagle’s medium SEM inhibitor of kappa B vascular cell adhesion molecule-1 Nitric oxide Hematoxylin and Eosin Monocyte chemotactic protein-1 mitogen-activated protein kinase total cholesterol high density lipoprotein cholesterol

Related Topics

Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine

Longxuetongluo capsule inhibits atherosclerosis progression in high-fat diet-induced ApoEâ/â mice by improving endothelial dysfunction

Authors

Jiao Zheng, Binglin Liu, Qixing Lun, Xiaopan Gu, Bo Pan, Yunfang Zhao, Wei Xiao, Jun Li, Pengfei Tu,